Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Breast Neoplasms 9 Pain, Postoperative 7 Lung Neoplasms 4 Depression 4 Brain Neoplasms 4 Anxiety Disorders 4 Prostatic Neoplasms 3 Pain 3 Ovarian Neoplasms 3 Neoplasms 3 Colonic Neoplasms 3 Agnosia 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Fallopian Tube Neoplasms 2 Delirium 2 Colorectal Neoplasms 2 Warts 1 Uterine Cervical Neoplasms 1 Trauma, Nervous System 1 Thrombosis 1 Synovial Cyst 1 Stroke 1 Spondylosis 1 Spondylolisthesis 1 Spinal Stenosis 1 Sleep Initiation and Maintenance Disorders 1 Sigmoid Neoplasms 1 Sepsis 1

Interventions

pembrolizumab 18 Nivolumab 13 avelumab 10 Ipilimumab 7 Specimen Handling 6 cemiplimab 5 atezolizumab 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Radiotherapy 3 Cyclophosphamide 3 prednylidene 2 poly ICLC 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 deltacortene 2 aldesleukin 2 Radiosurgery 2 Prednisone 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 CTLA-4 Antigen 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Saline Solution × 1 year × Clear all

NCT03271372 2026-05-12

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡